Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check3 days agoChange DetectedAn additional Study Status entry appears in the record history (version 18) dated around 2025-10-30/31. This indicates an update to the trial’s current status.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check39 days agoChange DetectedUpdate: Revision tag changed from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' link was removed as a minor UI change.SummaryDifference0.7%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%

- Check67 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as multiple updates to study statuses, indicating ongoing research activities.SummaryDifference15%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.